-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Dyne Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
- Dyne Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$65.1M, a 0.31% decline year-over-year.
- Dyne Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$258M, a 36.1% decline year-over-year.
- Dyne Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$236M, a 40.4% decline from 2022.
- Dyne Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$168M, a 12.6% decline from 2021.
- Dyne Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$149M, a 151% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)